DE1072360B - - Google Patents
Info
- Publication number
- DE1072360B DE1072360B DENDAT1072360D DE1072360DA DE1072360B DE 1072360 B DE1072360 B DE 1072360B DE NDAT1072360 D DENDAT1072360 D DE NDAT1072360D DE 1072360D A DE1072360D A DE 1072360DA DE 1072360 B DE1072360 B DE 1072360B
- Authority
- DE
- Germany
- Prior art keywords
- skin care
- water
- hydrocortisone
- care product
- borax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003491 Skin Anatomy 0.000 claims description 18
- 239000003246 corticosteroid Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 claims description 6
- 229960001334 Corticosteroids Drugs 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 claims description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 5
- 229960000890 hydrocortisone Drugs 0.000 claims description 5
- 239000004328 sodium tetraborate Substances 0.000 claims description 4
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 4
- 210000004080 Milk Anatomy 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 229960005205 prednisolone Drugs 0.000 claims description 2
- 239000003871 white petrolatum Substances 0.000 claims description 2
- 239000008132 rose water Substances 0.000 claims 3
- 244000144725 Amygdalus communis Species 0.000 claims 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N Benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 claims 2
- 235000020224 almond Nutrition 0.000 claims 2
- 230000001815 facial Effects 0.000 claims 2
- 239000000155 melt Substances 0.000 claims 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 1
- 241000581728 Chamaerhodos erecta Species 0.000 claims 1
- 239000004327 boric acid Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 230000001256 tonic Effects 0.000 claims 1
- 239000003925 fat Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 230000003356 anti-rheumatic Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940072033 potash Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- 210000004404 Adrenal Cortex Anatomy 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 229940096919 Glycogen Drugs 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N Prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- ORNBQBCIOKFOEO-QGVNFLHTSA-N Pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 description 1
- 229960000249 Pregnenolone Drugs 0.000 description 1
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 210000004304 Subcutaneous Tissue Anatomy 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940099259 Vaseline Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 229940045860 White wax Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- -1 steroid compounds Chemical class 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
Description
Die kosmetische Hautpflege dient dem Ziel, die normale Beschaffenheit der Haut zu erhalten. Für diesen Zweck sind schon die verschiedensten Mittel verwendet worden. Sie bestehen im allgemeinen aus einem Vehikel, z. B. einer Salben- oder Milchgrundlage, und einem wirksamen Bestandteil, z. B. Vitaminen u. dgl., und werden in der Regel als halbfette oder flüssige Emulsionen angewandt.The cosmetic skin care is aimed at normal Preserve the texture of the skin. A wide variety of means have been used for this purpose been. They generally consist of a vehicle, e.g. B. an ointment or milk base, and an effective ingredient, e.g. B. vitamins and the like, and are usually as semi-fat or liquid Emulsions applied.
Es ist bereits eine antirheumatisch wirkende Creme bekannt, die als Wirkstoff Cortison, Adrenalin oder andere eine antirheumatische Wirkung zeigende Derivate des Brenzkatechins enthält.There is already an anti-rheumatic cream known which, as an active ingredient, cortisone, adrenaline or contains other derivatives of catechol which have an anti-rheumatic effect.
Bekannt ist es ferner, Pregnenolon oder dessen Derivate, z. B. die Ester und Äther, als Bestandteile von Hautpflegemitteln zu verwenden.It is also known to use pregnenolone or its derivatives, e.g. B. the esters and ethers, as constituents of skin care products to use.
Schließlich sind auch Hautpflegemittel mit. einem Gehalt an verschiedenen physiologisch inaktiven Steroidverbindungen, \vie z. B. 17a-Äthy1-.d4-androstcn-17^-01-3-011, bekannt.Finally, skin care products are also included. a content of various physiologically inactive steroid compounds, \ vie z. B. 17a-Ethy1-.d 4 -androstcn-17 ^ -01-3-011, known.
Es wurde nun gefunden, daß die Steroide der Nebennierenrinde, d. h. die Corticosteroide, die bisher noch nicht in Hautpflegemitteln verwendet wurden, bei der Anwendung auf die menschliche Haut die folgenden Wirkungen ausüben:It has now been found that the adrenal cortex steroids, i.e. H. the corticosteroids that were previously used not yet used in skin care products when applied to human skin have the following effects:
Sie fördern den Glykogenaufbau des Unterhautzcllgewebes und regeln den Wasser- und Mineralhaushalt; sie tragen zur Aufrechterhaltung des Tonus der Kapillargefäße bei· und steuern die Wärmeregulieru.ng der Haut, mithin das Aussehen trotz .Temperatur- und Feuchtigkeitsschwankungen; sie schützen ferner gegen ultraviolette Strahlung, fördern die gleichmäßige Durchblutung und bewirken eine allgemeine Resistenzsteigerung durch Erhöhung der Abwehrfunktion der gesunden Haut.They promote the build-up of glycogen in the subcutaneous tissue and regulate the water and mineral balance; they help to maintain the tone of the capillary vessels and control the temperature regulation the skin, and therefore its appearance despite fluctuations in temperature and humidity; they also protect against ultraviolet radiation, promote even blood circulation and cause a general increase in resistance by increasing the immune system of healthy skin.
Gegenstand der Erfindung ist daher ein Hautpflegemittel, welches durch einen Gehalt an Corticosteroiden natürlicher oder synthetischer Herkunft gekennzeichnet ist.The subject matter of the invention is therefore a skin care product which contains corticosteroids of natural or synthetic origin.
Tm Rahmen der Erfindung sind zwar alle Corticosteroide und deren Abkömmlinge und Verbindungen verwendbar, indessen wird Hydrocortison auf Grund seiner besonders guten Wirksamkeit bevorzugt. Auch die synthetisch gewonnenen Corticosteroide, wie Prednison (zl^-Pregnadien-na^l-diol-S.ll^O-trion) und Prednisolon (zi1'4-Pregnadien-ll^,17a-21-triol-3,20-dion) (vgl. J. am. Chem. Soc, 77, 4781 bis 4784 119551 und Ulimanns Encyklopädie der technischen Chemie, Bd. 8, 1957, S. 667 und 685 bis 687), haben eine entsprechende Wirksamkeit.Although all corticosteroids and their derivatives and compounds can be used in the context of the invention, hydrocortisone is preferred because of its particularly good effectiveness. Also the synthetically obtained corticosteroids, such as prednisone (zl ^ -Pregnadien-na ^ l-diol-S.ll ^ O-trion) and prednisolone (zi 1 ' 4 -Pregnadien-ll ^, 17a-21-triol-3.20 -dion) (cf. J. am. Chem. Soc, 77, 4781 to 4784 119551 and Ulimanns Encyklopadie der technischen Chemie, Vol. 8, 1957, pp. 667 and 685 to 687) have a corresponding effectiveness.
Die erfindimgsgemäßen Hautpflegemittel enthalten die Corticosteroide zweckmäßig in einer Menge von etwa 1 bis 3fl/o, insbesondere etwa 2%.The skin care products according to the invention advantageously contain the corticosteroids in an amount of about 1 to 3 fl / o, in particular about 2%.
Als Grundlage für die crfindungsgemäBen Hautpflegemittel kann jedes beliebige Medium dienen, das HautpflegemittelAs a basis for the skin care products according to the invention any medium can serve, the skin care product
Anmelder:Applicant:
Dr. med. Gerhard Willich, Teheran (Iran)Dr. med. Gerhard Willich, Tehran (Iran)
Vertreter: Dr.-Ing. W. Abitz, Patentanwalt, München 27, Gaußstr. 6 .Representative: Dr.-Ing. W. Abitz, patent attorney, Munich 27, Gaußstr. 6th
Dr. med. Gerhard Willich, Teheran (Iran), ist als Erfinder genannt wordenDr. med. Gerhard Willich, Tehran (Iran), has been named as the inventor
mit den Corticosteroiden verträglich ist, z. B. eine der üblichen Grundlagen für Gesichtswässer, Kopfaremes, -emulsionen und -wasser oder auch Medien von festerer Konsistenz, z. B. Vaseline, die bekannten Cremegrundlagen und Schönheitsmilche.is compatible with the corticosteroids, e.g. B. one of the usual bases for facial lotions, head aremes, emulsions and water or media of a more solid consistency, e.g. B. Vaseline, the well-known cream base and beauty milk.
Nachfolgend wird zur beispielswei.sen Erläuterung der Erfindung die Herstellung einiger Hautpflegemittel beschrieben.In the following, the production of some skin care products is described by way of example to explain the invention described.
Man erhitzt in einem sehr geräumigen Gefäß auf dem Wasserbad 1501 g Stearin (Glycerinester der Palmitin- und Stearinsäure), 30g Vaselinöl, 5gCacaobutter, 10 g weißes Wachs und 20 g weiße Vaseline bis zum Schmelzen. Getrennt bereitet man eine Lösung von 15g Pottasche in 50 g Wasser und eine Lösung von 8 g Borax in 850 g Wasser. Sobald das Stearin und die anderen Fette geschmolzen sind, wird zuerst die konzentrierte Pottaschelösung zum Sieden erhitzt und nach und nach, aber ziemlich flott, unter Umrühren in die Fettschmelze eingetragen. Die Masse wird ständig gerührt; sobald sie nicht mehr steigt, setzt man die zum Sieden erhitzte Boraxlösung unter Umrühren rasch zu und erhitzt dann zum Sieden. Man setzt das leichte Durchsieden der Masse unter Rühren etwa Vj Stunde fort, nimmt sie dann vom Feuer, gleicht eventuelle Wasserverluste aus und kühlt unter ständigem weiterem Rühren bis zum Dickwerden der Masse. Bei beginnender Erstarrung arbeitet man 3% Hydrocortison ein. M to heated g in a very large vessel on the water bath 150 1 stearin (Glycerinester of palmitic and stearic acid), 30 g vaseline, 5gCacaobutter, 10 g of white wax and 20 g of white petrolatum until melted. A solution of 15 g of potash in 50 g of water and a solution of 8 g of borax in 850 g of water are prepared separately. As soon as the stearin and the other fats have melted, the concentrated potash solution is first heated to the boil and gradually, but fairly quickly, added to the molten fat while stirring. The mass is constantly stirred; as soon as it no longer rises, the borax solution, which has been heated to the boil, is added quickly while stirring and then heated to the boil. Continue the gentle simmering of the mass with stirring for about an hour, then remove it from the fire, compensate for any losses of water and cool with constant further stirring until the mass becomes thick. When solidification begins, 3% hydrocortisone is incorporated.
Man erhält eine glatte, körnchenfreie, in ausgezeichneter Weise als Hautpflegemittel geeignete Creme.A smooth, grain-free cream is obtained which is excellently suited as a skin care product.
H e i s ρ i e. 1 2H e i s ρ i e. 1 2
lune fettere 1 Iautpflegecrcme wird hergestellt, indem man 40 g Cetylalkohol, 145 g Paraffin, 240 g La-lune fattere 1 Iautpflegecrcme is made by one 40 g of cetyl alcohol, 145 g of paraffin, 240 g of La-
909 707/316909 707/316
Claims (1)
Beispiel 3 ; π . . , “Table purposes.
Example 3
8 Tage absitzen, gießt durch ein engmaschiges Sieb Deutsche Patentschrift Nr. 950 960;
ab. und setzt gegebenenfalls Parfümstoffe zu. 25 belgische Patentschriften Nr. 524 132, 531 437;incorporated into the paste with constant rubbing, resulting in a rather thick milk. Considered publications are allowed:
Sit for 8 days, pour through a close-meshed sieve German Patent No. 950 960;
away. and optionally adds perfumes. 25 Belgian patents Nos. 524 132, 531 437;
Publications (1)
Publication Number | Publication Date |
---|---|
DE1072360B true DE1072360B (en) | 1959-12-31 |
Family
ID=596845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT1072360D Pending DE1072360B (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1072360B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19643587A1 (en) * | 1996-10-22 | 1998-04-23 | Beiersdorf Ag | Antiadhesive sterols and sterol derivatives |
-
0
- DE DENDAT1072360D patent/DE1072360B/de active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19643587A1 (en) * | 1996-10-22 | 1998-04-23 | Beiersdorf Ag | Antiadhesive sterols and sterol derivatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1103521B (en) | Means for tanning the skin | |
DE69926881T2 (en) | PREPARATIONS FOR ACNE TREATMENT | |
DE602004004880T2 (en) | SKIN CARE PRODUCT WITH TALL OIL FATTY ACIDS AND PLANT OILS FOR DRY AND DANDRATING SKIN AND TREATMENT OF PSORIASIS, DERMATITIS AND ECCEMENTS | |
DE1492118C3 (en) | Personal care products | |
DE3615396A1 (en) | Compositions for treating the hair and the scalp | |
DE1072360B (en) | ||
DE1067180B (en) | skin care products | |
DE3526669C2 (en) | ||
DE602004007164T2 (en) | TRANSPORT AND ABSORPTION AGENTS AND THE METHOD OF ITS MANUFACTURE FROM HEMS | |
DE2654743C2 (en) | Use of a mixture as a therapeutic agent for the external treatment of psoriasis, lichen and eczema | |
DE972443C (en) | Skin care products | |
DE2154526C3 (en) | Hair treatment compositions and processes for their manufacture | |
DE1492125A1 (en) | Gel-like cosmetic preparation | |
CH399655A (en) | Skin care products | |
DE2725765A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING THIAZOLE DERIVATIVES | |
DE1467964C3 (en) | Cosmetic means | |
DE1492177C3 (en) | Skin treatment agents | |
DE714089C (en) | Light stabilizers | |
DE3601739A1 (en) | Cosmetic composition for treating the hair or the scalp | |
CH634988A5 (en) | Cosmetic light-stabilising agent for the UV-A region | |
DE866830C (en) | Skin care products and processes for their manufacture | |
DE1023561B (en) | Skin and hair care products | |
DE909984C (en) | Process for the production of durable, highly effective vitamin F preparations | |
DE2155642A1 (en) | Preparations made from a cosmetic, moisture-repellent and therapeutic emulsion | |
DEC0008373MA (en) |